Please log in to see the full text of this API!

Prazosin

  • ATC: C02CA01
  • Use: Lorem  Lorem  Lorem 
  • Chemical name: Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
  • Formula: Lorem ipsum dolor sit amet,
  • MW:383.41 g/mol
  • CAS-RN:19216-56-9
  • InChI Key:IENZQIKPVFGBNW-UHFFFAOYSA-N
  • InChI:InChI=1S/C19H21N5O4/c1-​26-​15-​10-​12-​13(11-​16(15)​27-​2)​21-​19(22-​17(12)​20)​24-​7-​5-​23(6-​8-​24)​18(25)​14-​4-​3-​9-​28-​14/h3-​4,​9-​11H,​5-​8H2,​1-​2H3,​(H2,​20,​21,​22)
  • EINECS:242-885-8
  • LD50: >400 mg/kg (M, i.v.); >4 g/kg (M, p.o.)

Derivatives

    monohydrochloride

  • Formula: C19H21N5O4 • HCl
  • MW:419.87 g/mol
  • CAS-RN:19237-84-4
  • EINECS:242-903-4
  • LD50: 92 mg/kg (M, i.v.); 5 g/kg (M, p.o.);
    73 mg/kg (R, i.v.); 1950 mg/kg (R, p.o.);
    >700 mg/kg (dog, p.o.)

Substance Classes

Synthesis Path








Substances Referenced in Synthesis Path

CAS-RN Formula Chemical Name CAS Index Name
23680-84-4 C10H10ClN3O2 4-amino-2-chloro-6,7-dimethoxyquinazoline 4-Quinazolinamine, 2-chloro-6,7-dimethoxy-
5653-40-7 C9H11NO4 2-amino-4,5-dimethoxybenzoic acid Benzoic acid, 2-amino-4,5-dimethoxy-
27631-29-4 C10H8Cl2N2O2 2,4-dichloro-6,7-dimethoxyquinazoline Quinazoline, 2,4-dichloro-6,7-dimethoxy-
28888-44-0 C10H10N2O4 2,4-dihydroxy-6,7-dimethoxyquinazoline 2,4(1H,3H)-Quinazolinedione, 6,7-dimethoxy-
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem

Trade Names

Country Trade Name Vendor Annotation
D Lorem Lorem
Lorem Lorem
F Lorem Lorem
Lorem Lorem
GB Lorem Lorem
I Lorem Lorem ,1978
J Lorem Lorem
USA Lorem Lorem
(wfm = withdrawn from market)

Formulations

  • Loremipsumdolorsitamet,consetetursadipscingelitr,seddiamnonumyeirmodtemporinviduntutlaboreetdoloremagnaaliquyamerat,sed

References

    • US 9 999 999 (Pfizer; 12.5.1970; appl. 13.12.1967; prior. 6.8.1965, 7.6.1966).
    • US 9 999 999 (Pfizer; 18.1.1972; prior. 6.8.1965, 7.6.1966, 13.12.1967).
    • US 9 999 999 (Pfizer; 16.5.1972; prior. 6.8.1965, 13.12.1967, 12.5.1970).
    • DAS 9 999 999 (Pfizer; appl. 2.7.1966; USA-prior. 6.7.1965, 7.6.1966).
  • alternative synthesis:

    • US 9 999 999 (Pfizer; 27.1.1976; prior. 5.12.1973).
    • DOS 9 999 999 (Pfizer; appl. 4.12.1974; USA-prior. 5.12.1973).
    • DOS 9 999 999 (Pfizer; appl. 11.7.1977; USA-prior. 6.8.1976).
    • US 9 999 999 (Pfizer; 13.12.1977; appl. 20.9.1976).
    • US 9 999 999 (Bristol-Myers; 6.2.1979; prior. 30.9.1977).
    • BE 999 999 (Fermion; appl. 14.12.1977; SF-prior. 15.12.1976).
    • BE 999 999 (Fermion; appl. 14.12.1977; SF-prior. 15.12.1976).
  • α-form:

    • US 9 999 999 (Pfizer; 30.5.1978; appl. 1.3.1976).
    • DAS 9 999 999 (Pfizer; appl. 25.2.1977; USA-prior. 1.3.1976).
  • anhydrous crystalline form:

    • DE 9 999 999 (Orion; appl. 9.8.1984; FL-prior. 25.6.1984).
    • US 9 999 999 (Heumann Pharma; 28.3.1989; appl. 3.3.1987; EP-prior. 21.3.1986).
  • metabolites of prazosin:

    • Althuis, T.H. et al.: J. Med. Chem. (JMCMAR) 20, 146 (1976).
Cookie-Einstellungen